ABBV vs ADSK · P/E 81, rev $16.99B vs P/E 65, rev $3.98B
AbbVie Inc (ABBV) versus Autodesk Inc (ADSK) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Autodesk Inc (ADSK) is a software - application company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ADSK revenue for 2026-07-31 was $3.98B. Net income was $983.0M. ADSK currently screens at market cap $67.33B and trailing P/E 65.4.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ADSK currently screens at market cap $67.33B and trailing P/E 65.4.
Not investment advice. Open the ABBV and ADSK stock pages for the full models.
Not investment advice.